Zobrazeno 1 - 10
of 118
pro vyhledávání: '"John McMannis"'
Autor:
Mamatha Seethammagari, John McMannis, David M. Spencer, Kevin M. Slawin, Annemarie Moseley, Guru Sonpavde, Joan M C Bull, Theresa K. Dancsak, Natasha Lapteva, Victoria E Hawkins, Yu Bai, Jonathan M. Levitt
Publikováno v:
Cancer Immunology, Immunotherapy. 66:1345-1357
This phase I trial reports the safety and activity of BPX101, a second-generation antigen-targeted autologous antigen presenting cell (APC) vaccine in men with metastatic castration-resistant prostate cancer (mCRPC). To manufacture BPX101, APCs colle
Autor:
Minoko Takanashi, David F. Stroncek, Jose A. Cancelas-Peres, Zbigniew M. Szczepiorkowski, Derwood Pamphilon, Eileen Selogie, Jo Anna Reems, Hermann Eichler, Ron Sacher, Henk S.P. Garritsen, David H. McKenna, Leo M.G. van de Watering, John McMannis
Publikováno v:
Cytotherapy. 15:255-262
Background aims Wide acceptance of the colony-forming unit (CFU) assay as a reliable potency test for stem cell products is hindered by poor inter-laboratory reproducibility. The goal of this study was to ascertain current laboratory practices for pe
Autor:
Mary J. Laughlin, Stephen R. Spellman, Pablo Rubinstein, Robert Chow, Jo Anna Reems, Lisa Phillips-Johnson, Carolyn Katovich Hurley, Colleen Brady, Joanne Kurtzberg, Donna Regan, John McMannis
Publikováno v:
Cytotherapy. 13:848-855
The following commentary was developed by the National Marrow Donor Program Cord Blood Advisory Group and is intended to provide an overview of umbilical cord blood (UCB) processing, summarize the current state of potency assays used to characterize
Autor:
Gabriela Rondon, Ying Jiang, Stefan O. Ciurea, Marcos de Lima, Victor E. Mulanovich, John McMannis, Elizabeth J. Shpall, Richard E. Champlin, Roland Bassett
Publikováno v:
Biology of Blood and Marrow Transplantation. 17:1169-1175
Alternative donor stem cell transplantation from cord blood or haploidentical peripheral blood donors is increasingly being used for patients who lack a matched related or unrelated donor. A higher nonrelapse mortality (NRM) rate has been noted with
Autor:
Richmond Thompson, Richard E. Champlin, Veronica R. Smith, Chitra Hosing, Muzaffar H. Qazilbash, John McMannis, Uday R. Popat, Kent Walters, Issa F. Khouri, Marcos de Lima, Sergio Giralt, Richard J. Balzer, Beverly Rhodes
Publikováno v:
Transfusion. 51:1300-1313
BACKGROUND: The purpose of this study was to perform a detailed analysis of the charges associated with chemomobilization and remobilization of autologous hematopoietic stem cells (HSCs) and to quantify medical costs and resource utilization associat
Publikováno v:
ISBT Science Series. 6:165-168
As applications in cellular therapies (CT) increase, so does the importance of international cooperation to facilitate the development of resources that best serve donors, healthcare professionals, and patients. Towards this goal, the AABB and Intern
Autor:
Maria Nawrot, Toni Temples, Ning Yuan, Elke Grassman, Zbigniew M. Szczepiorkowski, John McMannis, Deanna Nielsen, Bert Wognum, David H. McKenna, Darin Sumstad, Helen Belfield, Jo Anna Reems
Publikováno v:
Transfusion. 51:2001-2005
BACKGROUND: Interlaboratory scoring performances were determined using a traditional 14-day colony-forming unit (CFU) assay and a new 7-day CFU assay. STUDY DESIGN AND METHODS: Digital images of colonies were utilized to train personnel at each site.
Publikováno v:
Biology of Blood and Marrow Transplantation. 17(2):176-189
Autor:
Helen Belfield, Derwood Pamphilon, David H. McKenna, Jo Anna Reems, Zbigniew M. Szczepiorkowski, Lucilla Lecchi, John McMannis, Elinor Curnow
Publikováno v:
Transfusion. 51:1284-1290
BACKGROUND: Most hematopoietic progenitor cell (HPC) products are infused or processed shortly after collection, but in some cases this may be delayed for up to 48 hours. A number of variables such as temperature and cell concentration are of critica
Autor:
M. Keating, Charles E. Prussak, Januario E. Castro, Deepa Sampath, John McMannis, Thomas J. Kipps, Annette Jalayer, R.A. Aguillon, William G. Wierda
Publikováno v:
Leukemia. 24:1893-1900
Ligation of CD40 on chronic lymphocytic leukemia (CLL) cells induces phenotypic and biochemical changes that facilitate CLL cell-T cell interactions and enhances the sensitivity of CLL cells to clearance by adaptive and innate immune-effector mechani